The Impact of Disease Activity on SD and ED in Patients With Inflammatory Bowel Disease (Sept, 10.1093/ibd/izac204, 2022)

被引：0
|
作者：
Mules, Thomas C.
Swaminathan, Akhilesh
Hirschfeld, Esther
Borichevsky, Grace M.
Frampton, Chris M.
Day, Andrew S.
Gearry, Richard B.
机构：
来源：
INFLAMMATORY BOWEL DISEASES | 2023年 / 29卷 / 02期
关键词：
D O I：
10.1093/ibd/izac258
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：337 / 337
页数：1
相关论文
共 50 条
  • [41] Commentary: impact of disease activity at conception on disease activity during pregnancy in patients with inflammatory bowel disease
    De Lima, A.
    van der Woude, C. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (07) : 842 - 842
  • [42] Mesalamine does not impact on thiopurine-methyl-transferase (TPMT) activity in inflammatory bowel disease (IBD) patients
    Daperno, Marco
    Sostegni, Raffaello
    Canaparo, Roberto
    Vernetto, Annalisa
    Serpe, Loredana
    Blanco, Ilenia
    Barbera, Cristiana
    D'Antico, Sergio
    Pera, Angelo
    Zara, Gian Paolo
    Rocca, Rodolfo
    GASTROENTEROLOGY, 2008, 134 (04) : A205 - A206
  • [43] The Longitudinal Impact of Serotonin Reuptake Inhibitors on Quality of Life and Disease Activity in Adults With Inflammatory Bowel Disease (IBD)
    Rives, Claudia M. Ramos
    Binion, David G.
    Youk, Ada
    Regueiro, Miguel
    Dunn, Michael A.
    Hashash, Jana G.
    Schwartz, Marc
    Baidoo, Leonard
    Barrie, Arthur
    Swoger, Jason M.
    Szigethy, Eva
    GASTROENTEROLOGY, 2014, 146 (05) : S456 - S456
  • [44] Fungal Microbiota Composition in Inflammatory Bowel Disease Patients: Characterization in Different Phenotypes and Correlation With Clinical Activity and Disease Course (dec, 10.1093/ibd/izad289, 2023)
    Catalan-Serra, Ignacio
    Thorsvik, Silje
    Beisvag, Vidar
    Bruland, Torunn
    Underhill, David
    Sandvik, Arne Kristian
    Granlund, Atle van Beelen
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (05) : 876 - 876
  • [45] Instruments to measure the impact of inflammatory bowel disease (IBD) on patients' daily life.
    Pastoor, CJ
    Russel, MG
    Stockbrugger, RW
    GASTROENTEROLOGY, 1996, 110 (04) : A988 - A988
  • [46] Impact of Sociodemographic Status on Hospital Length of Stay in Inflammatory Bowel Disease (IBD) Patients
    Parraga, Carla Barberan
    Jana, Kundan
    Sierra, Leandro
    Ehrlich, Samantha S.
    Ozturk, Nazli Begum
    Salem, Ahmed E.
    Kantrowitz, Michael
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S904 - S904
  • [47] How accurate are clinical activity indices for scoring of disease activity in inflammatory bowel disease (IBD)?
    Jorgensen, LGM
    Fredholm, L
    Petersen, PH
    Hey, H
    Munkholm, P
    Brandslund, I
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2005, 43 (04) : 403 - 411
  • [48] Correlation Between Serological Biomarkers and Clinical Activity in Patients With Inflammatory Bowel Disease (IBD)
    Chaparro, Maria
    Miranda-Garcia, Pablo
    Gisben, Javier P.
    GASTROENTEROLOGY, 2011, 140 (05) : S425 - S425
  • [49] Correlation Between Serological Biomarkers and Clinical Activity in Patients With Inflammatory Bowel Disease (IBD)
    Miranda-Garcia, Pablo
    Chaparro, Maria
    Gisbert, Javier P.
    GASTROENTEROLOGY, 2012, 142 (05) : S654 - S654
  • [50] LIVER DISEASE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): CAUSES, PRESENTATIONS AND OUTCOMES
    Warner, B. D.
    Basra, M.
    Anderson, S.
    Irving, P.
    Sanderson, J.
    GUT, 2016, 65 : A140 - A141
12345